Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SABRATEK CORP (SBTK) -- Ignore unavailable to you. Want to Upgrade?

To: Pluvia who wrote (161)	6/17/1999 9:23:00 AM
From: Swanny	Read Replies (1) \| Respond to of 487

What's the matter, Steve? Did you run out of bullets already? Can't you get Dan Dorfman to do a report on the company? You also forgot Bad News #'s 4 & 5. The stock could fall substantially if explosions occur simultaneously in all Sabratek facilities or if all Sabratek officers and employees die from a mysterious disease.

To: Pluvia who wrote (161)	6/17/1999 11:53:00 AM
From: mod	Respond to of 487

Pluvia, Gee, left out a few material facts, didn't you? Maybe you need remedial 8-K reading lessons. Like if their SBTK is sold for more then $21.11, they pay the excess to the company. With the current SBTK price over $23, and the likelihood it will move higher, there will be a nice gain to SBTK if the shares are sold. I like this provision. Next time, include all the facts, not just the facts your "we just paid $50 million because we were VERY BAD" lawyers want you to spin. mod